Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and Evergreen Theragnostics, Inc., a radiopharmaceutical contract manufacturer, today announced that the companies have entered into an agreement whereby Evergreen will provide US-based manufacturing for Precirix's lead product candidate, CAM-H2.
April 28, 2021
Precirix partners with Evergreen to expand North American clinical trial supply.
"Approved suggestion from source: https://www.prnewswire.com/news-releases/precirix-partners-with-evergreen-to-expand-north-american-clinical-trial-supply-301278235.html"
approved a suggestion from Golden's AI on 29 Apr, 2021
Edits made to:
Timeline (+1 events) (+349 characters)
Timeline
April 28, 2021
Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and Evergreen Theragnostics, Inc., a radiopharmaceutical contract manufacturer, today announced that the companies have entered into an agreement whereby Evergreen will provide US-based manufacturing for Precirix's lead product candidate, CAM-H2.